| LOSS PER SHARE |
NOTE
15 - LOSS PER SHARE
Basic
and diluted net loss per share was determined by dividing net loss attributable to common stockholders by the weighted-average common
shares outstanding during the period.
The
following table sets forth the computation of basic and diluted net loss per share for the periods indicated:
SCHEDULE OF COMPUTATION OF BASIC AND DILUTED NET LOSS PER SHARE
| Basic and diluted net loss per share | |
2026 | | |
2025 | | |
2026 | | |
2025 | |
| | |
Three months ended, June 30 | | |
Six months ended, June 30 | |
| Basic and diluted net loss per share | |
2026 | | |
2025 | | |
2026 | | |
2025 | |
| | |
| | |
| | |
| | |
| |
| Numerator: | |
| | | |
| | | |
| | | |
| | |
| Net loss | |
$ | (13,876,277 | ) | |
$ | (2,237,988 | ) | |
$ | (28,523,232 | ) | |
$ | (3,808,163 | ) |
| Denominator: | |
| | | |
| | | |
| | | |
| | |
| Weighted-average shares outstanding | |
| 54,112,845 | | |
| 37,784,611 | | |
| 52,767,635 | | |
| 37,784,611 | |
| Net loss per share of common stock - Basic and Diluted | |
$ | (0.26 | ) | |
$ | (0.06 | ) | |
$ | (0.54 | ) | |
$ | (0.10 | ) |
The
following warrants to purchase common stock, RSUs, and options to purchase common stock have been excluded from the computation of net
loss per share of common stock for the periods presented because including them would have had an anti-dilutive effect:
SCHEDULE OF ANTI-DILUTIVE EFFECT OF NET LOSS PER SHARE
| | |
2026 | | |
2025 | | |
2026 | | |
2025 | |
| | |
Three months ended, June 30 | | |
Six months ended, June 30 | |
| | |
2026 | | |
2025 | | |
2026 | | |
2025 | |
| Warrants to purchase common stock | |
| 16,731,496 | | |
| 17,628,996 | | |
| 16,731,496 | | |
| 17,628,996 | |
| RSUs | |
| 937,500 | | |
| — | | |
| 937,500 | | |
| — | |
| Options to purchase common stock | |
| 15,113,046 | | |
| 15,113,046 | | |
| 15,113,046 | | |
| 15,113,046 | |
| Antidilutive securities excluded from computation of earnings per share, amount | |
| 32,782,042 | | |
| 32,742,042 | | |
| 32,782,042 | | |
| 32,742,042 | |
|